Alloy Fund is a U.S.-based fund backing early-stage fintech, B2B technology, and biotech companies. Partners Bruno Faviero, Max Kolysh, and Mei Z. met as classmates at MIT before becoming angel investors, early operators, and VCs early in their careers. The partners bring a great mix of investing and operating experience to bear across industries and functional expertise. Bruno brings experience as a founder, having previously founded Synapse, which was acquired by Palantir in 2020. He also has experience in product, as a PM at Palantir post-acquisition, and in VC, as one of the founding partners of First Round’s Graduate Fund. Max brings expertise as a founder and CEO of Zinc and Dover. In addition, he serves as a senior venture partner for YC’s Pioneer Fund. Finally, Mei brings expertise as a VC at Romulus Capital, where she focused on investing in seed-stage companies.
Alloy Fund is part of a new cohort of venture funds that look to better serve founders by identifying with the challenges they face through shared experiences. As experienced operators, Bruno, Max, and Mei are able to offer empathy and guidance to founders as they build and scale their companies, and provide operational expertise across go-to-market, product, and engineering. Alloy aspires to write one of the first checks into companies at their earliest stages, and aims to help founders navigate the crucial company launch period.
Why we invested
The partners at Alloy Fund understand what it takes to be a successful founder. They took risks and made big bets on themselves early in their careers, and their hard work paid off. It’s for these reasons that they’re often one of the first calls their founders make when they’re encountering a problem or want to brainstorm ideas. We were impressed with all three partners’ thematic approach to investing, as well as their ability to network their way into competitive deals. Alloy is emblematic of the rapidly changing face of early-stage VC, and we’re excited to see how the firm continues to help founders at their earliest stages.